Skip to main content
TipRanks
Go Ultimate75% OFF

John Rhodes Insider Profile

4 Followers

John Rhodes, Director at Tonix Pharma, holds 23.47K shares in Tonix Pharma (Ticker: TNXP). Most recently, John Rhodes Bought 7,500 shares of Tonix Pharma on Jun 06, 2018 for an estimated value of $24.98K.

John Rhodes's Trading History

TNXP
Tonix Pharma
Jun 06, 2018DirectorInformative Buy24.98K$70.64K
TNXP
Insider Shares: 23.47K (0.29%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 06, 2018Informative Buy$24.98K7,500$3.33-96.00%
Mar 09, 2018Uninformative Buy$7.33K2,850$2.57―
Oct 31, 2016Uninformative Buy$0.0025,000$0.00―
Jun 21, 2016Informative Buy$50.00K25,000$2.00-79.20%
Jul 17, 2015Informative Buy$45.00K6,000$7.50-76.40%

You May Also Like

John Rhodes insider profile FAQ

What is the percentage of profitable transactions made by John Rhodes?
The percentage of profitable transactions made by John Rhodes is 0%.
What is the average return per transaction made by John Rhodes?
The average return per transaction made by John Rhodes is -83.80%.
What stocks does John Rhodes hold?
John Rhodes holds: TNXP stocks.
What was John Rhodes’s latest transaction?
John Rhodes’s latest transaction was an Informative Buy of $24.98K.
What was John Rhodes's most profitable transaction?
John Rhodes’s most profitable transaction was an Informative Buy of TNXP stock on July 17, 2015. The return on the trade was -76.40%.
What is John Rhodes's role in Tonix Pharma?
John Rhodes's role in Tonix Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.